Effect of adjusting the combination of budesonide/formoterol on asthma management for 24 weeks

Effect of adjusting the combination of budesonide/formoterol on asthma management for 24 weeks - Effect of ICS/LABA on asthma management

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009599

Enrollment

Registered

2012-12-21

Start date

2011-01-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with asthma who are stable at least last 4 weeks.

Exclusion criteria

Exclusion criteria: Patients who need the corticosteroid excepting the inhale corticosteroid. Patients with other respiratory diseases, malignant diseases, pregnancy and/or lactation.

Design outcomes

Primary

Measure	Time frame
asthmatic symptpms and peak expiratory flow rate	—

Countries

Japan

Contacts

Public Contactsyomuka

Dokkyo Medical University The ethics committee

syomuka@dokkyomed.ac.jp0282-86-1111

Outcome results